Stock Taper 
CATALIO CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Eledon Pharmaceuticals, Inc. | ELDN | 1.7M | $6.68M |
 Avalyn Pharma Inc. Common Stock | AVLN | 1.68M | $55.17M |
 Syndax Pharmaceuticals, Inc. | SNDX | 1.22M | $26.58M |
 Corvus Pharmaceuticals, Inc. | CRVS | 1.08M | $16.15M |
 Applied Aerospace & Defense, Inc. | AADX | 824.04K | $22.55M |
 Mineralys Therapeutics, Inc. | MLYS | 648.72K | $17.5M |
 Heartflow, Inc. Common Stock | HTFL | 583.05K | $17.11M |
 Definium Therapeutics, Inc. | DFTX | 562.67K | $26.47M |
 Septerna Inc | SEPN | 536.15K | $17.96M |
 Protara Therapeutics, Inc. | TARA | 520.15K | $1.99M |
 4D Molecular Therapeutics, Inc. | FDMT | 471.25K | $6.27M |
 Kailera Therapeutics, Inc. | KLRA | 468.75K | $10.33M |
 Odyssey Therapeutics, Inc. | ODTX | 457.84K | $8.57M |
 BridgeBio Pharma, Inc. | BBIO | 455.04K | $33.89M |
 Bristol-Myers Squibb Company | BMY | 412.96K | $23.79M |
 Ultragenyx Pharmaceutical Inc. | RARE | 316.25K | $10.56M |
 Kardigan, Inc. | KARD | 312.5K | $7.45M |
 Gilead Sciences, Inc. | GILD | 269.31K | $34.02M |
 Dyne Therapeutics, Inc. | DYN | 244.93K | $5.44M |
 Atai Beckley Inc. | ATAI | 196.86K | $1.04M |